Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Marc Phelip

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
European Radiology|November 21, 2024
Cryoablation for treatment of peripheral lung metastases from colorectal cancer: a bicenter retrospective studyJean Izaaryene, Rémi Grange, Vincent Habouzit, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 14, 2015
FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802)Thomas Aparicio, Benjamin Linot, Karine Le Malicot, et al.
BMC Cancer|July 27, 2016
Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programAntoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
ESMO Open|June 4, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT studyJean-Baptiste Bachet, Lucjan Wyrwicz, Timothy Price, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 19, 2020
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Frederic Di Fiore, Olivier Bouché, Come Lepage, et al.
Endoscopic Ultrasound|October 5, 2023
The level of glucose in pancreatic cyst fluid is more accurate than carcinoembryonic antigen to identify mucinous tumors: A French multicenter studyNicolas Williet, Fabrice Caillol, David Karsenti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 5, 2020
Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III studySylvain Manfredi, Anthony Turpin, David Malka, et al.
Gut|October 16, 2010
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)Laetitia Dahan, Frank Bonnetain, Marc Ychou, et al.
British Journal of Cancer|November 23, 2021
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trialsDaniel Pietrasz, Shufang Wang-Renault, Julien Taieb, et al.
Scientific Reports|July 18, 2018
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional surveyJulien Langrand-Escure, Peng Diao, Max-Adrien Garcia, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
European Radiology|November 21, 2024
Cryoablation for treatment of peripheral lung metastases from colorectal cancer: a bicenter retrospective studyJean Izaaryene, Rémi Grange, Vincent Habouzit, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 14, 2015
FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802)Thomas Aparicio, Benjamin Linot, Karine Le Malicot, et al.
BMC Cancer|July 27, 2016
Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use programAntoine Adenis, Christelle de la Fouchardiere, Bernard Paule, et al.
ESMO Open|June 4, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT studyJean-Baptiste Bachet, Lucjan Wyrwicz, Timothy Price, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 19, 2020
COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR)Frederic Di Fiore, Olivier Bouché, Come Lepage, et al.
Endoscopic Ultrasound|October 5, 2023
The level of glucose in pancreatic cyst fluid is more accurate than carcinoembryonic antigen to identify mucinous tumors: A French multicenter studyNicolas Williet, Fabrice Caillol, David Karsenti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 5, 2020
Maintenance treatment with fluoropyrimidine plus bevacizumab versus fluoropyrimidine alone after induction chemotherapy for metastatic colorectal cancer: The BEVAMAINT - PRODIGE 71 - (FFCD 1710) phase III studySylvain Manfredi, Anthony Turpin, David Malka, et al.
Gut|October 16, 2010
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)Laetitia Dahan, Frank Bonnetain, Marc Ychou, et al.
British Journal of Cancer|November 23, 2021
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trialsDaniel Pietrasz, Shufang Wang-Renault, Julien Taieb, et al.
Scientific Reports|July 18, 2018
Outcome and prognostic factors in 593 non-metastatic rectal cancer patients: a mono-institutional surveyJulien Langrand-Escure, Peng Diao, Max-Adrien Garcia, et al.
Pageof 12